Using SAFEPATH to Uncover a Novel Mechanism of Hepatotoxicity for Gefitinib
Layla Hosseini-Gerami, Sara Masarone, Jordan S. Lane
This study uses SAFEPATH to identify a novel sphingolipid metabolism mechanism of Gefitinib toxicity and validate it experimentally, while recovering the known UGT1A1-mediated toxicity of Erlotinib.
bioRxiv · Jul 31, 2024 · PreprintSystems Biology